Clinical trial
Telomere Length and Telomerase Activity as a Predictor of Acute Kidney Injury Following Cardiac
NCT02692833 is registered in ClinicalTrials.gov with Queen Mary University of London as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Telomere Length and Telomerase Activity as a Predictor of Acute Kidney Injury Following Cardiac
- Lead sponsor
- Queen Mary University of London
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 31, 2016
- Completion date
- May 31, 2017
- Enrollment
- 254 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.